Exact Mass: 426.1274
Exact Mass Matches: 426.1274
Found 167 metabolites which its exact mass value is equals to given mass value 426.1274
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Mometasone
Mometasone is a medium-potency synthetic corticosteroid with antiinflammatory, antipruritic, and vasoconstrictive properties. Studies in asthmatic patients have demonstrated that mometasone provides a favorable ratio of topical to systemic activity due to its primary local effect along with the extensive hepatic metabolism and the lack of active metabolites. Though effective for the treatment of asthma, glucocorticoids do not affect asthma symptoms immediately. Maximum improvement in symptoms following inhaled administration of mometasone furoate may not be achieved for 1 to 2 weeks or longer after starting treatment. he antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents
Nicarbazin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
Butanoic acid, 3-((2-naphthalenylsulfonyl)amino)-4-oxo-4-((2-phenylethyl)amino)-, (S)-
Vericiguat
Villosinol
11-Hydroxytephrosin
5-Hydroxy-8-(4-hydroxy-3,5-dimethoxyphenyl)-10-methoxy-2,2-dimethyl-2H,6H-benzo[1,2-b:5,4-b]dipyran-6-one
5-Hydroxy-3,8-dimethoxy-3,4-methylenedioxy-7-prenyloxyflavone
N-Fructosyl gamma-glutamyl-S-methylcysteine
Annotation level-3
2-acetyl-1,3-dicoumaroylglycerol|2-acetyl-1,3-di[(E)-p-coumaroyl]glycerol|Lasiocarpin A
(1R,2S,3R,4S)-1-Ac,1,3-debenzoyl-5-(Hydroxymethyl)-5-cyclohexene-1,2,3,4-tetrol|acetyl piperenol A
uvarirufol B|{(1R,4S,5R,6S)-6-acetoxy-1,4-dihydroxy-5-[(benzoyl)oxy]cyclohex-2-en-1-yl}methyl benzoate
(-)-6-acetylzeylenol|(-)-6-O-acetyl-1-benzoyloxymethylcyclohex-4-en-1,2,3,6-tetrol
2-(1,3-Benzodioxole-5-yl)-3,5-dimethoxy-7-(2-hydroxy-3-methyl-3-butenyloxy)-4H-1-benzopyran-4-one
(-)-deguoic acid|5-(6,7-dimethoxy-2,3-dihydrochromon-3-oxy) beta-tubaic acid
(-)-rotoic acid|4-(2,3-dihydro-6,7-dimethoxychromon-3-oxy) tubaic acid
Cys Cys Thr Thr
Cys Met Ser Ser
Cys Ser Met Ser
Cys Ser Ser Met
Cys Thr Cys Thr
Cys Thr Thr Cys
Met Cys Ser Ser
Met Ser Cys Ser
Met Ser Ser Cys
Ser Cys Met Ser
Ser Cys Ser Met
Ser Met Cys Ser
Ser Met Ser Cys
Ser Ser Cys Met
Ser Ser Met Cys
Thr Cys Cys Thr
Thr Cys Thr Cys
Thr Thr Cys Cys
2,2-(5-Bromo-2-fluoro-1,3-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
Fenbenicillin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
2,4-DIFLUORO-N-(2-METHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)BENZENESULFONAMIDE
U0126-EtOH
U0126 (U0126-EtOH) is a potent, non-ATP competitive and selective MEK1 and MEK2 inhibitor, with IC50s of 72 nM and 58 nM, respectively. U0126 is an autophagy and mitophagy inhibitor[1][2][3][4].
p-Nitrophenyl 2-Acetamido-2-deoxy-3,6-di-O-acetyl-β-D-glucopyranoside
Pregna-1,4-diene-3,20-dione,9,11-dichloro-17,21-dihydroxy-16-methyl-, (11b,16a)-
Vericiguat
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan
4,18-Dihydroxy-15-(3-hydroxy-3-methylbutyl)-2-methoxy-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
(E)-N-[[4-(morpholin-4-ylmethyl)phenyl]carbamothioyl]-3-(3-nitrophenyl)prop-2-enamide
3-[[2-[[4-Ethyl-5-[(3-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]benzoic acid
2-[[2-[(3,7-Dimethyl-2-quinolinyl)thio]-1-oxoethyl]amino]-4,5-dimethoxybenzoic acid
N-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-4-oxo-1-benzopyran-2-carboxamide
N-[3-(1-azepanylsulfonyl)phenyl]-4-oxo-1-benzopyran-2-carboxamide
2-(4-oxo-3-quinazolinyl)-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide
2-[4-(5-{[(2-Methylphenyl)sulfonyl]methyl}-2-furoyl)piperazin-1-yl]pyrimidine
ethyl (2Z)-2-[(5Z)-3-[2-(furan-2-ylmethylamino)-2-oxoethyl]-5-[(4-methylphenyl)methylidene]-4-oxo-1,3-thiazolidin-2-ylidene]acetate
(1R,5S)-7-[4-(2-fluorophenyl)phenyl]-6-(3-fluorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
15-(1,3-Dihydroxy-3-methylbutyl)-18-hydroxy-2-methoxy-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
1,3,5-Benzenetricarboxylic acid tri(trimethylsilyl) ester
13,21-Dihydroxy-16,17-dimethoxy-6-prop-1-en-2-yl-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one
2-(4-(4-Nitrophenyl)-6-phenyl-2-pyrimidinylamino)benzoic acid methyl ester
1,2,3-Benzenetricarboxylic acid tri(trimethylsilyl) ester
Mometasone
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents
S-butyryl-4-phosphopantetheine(2-)
An S-acyl-4-phosphopantetheine obtained by deprotonation of the phosphate OH groups of S-butyryl-4-phosphopantetheine; major species at pH 7.3.
(1r,4s,5r,6s)-6-(acetyloxy)-5-[(benzoyloxy)methyl]-4,5-dihydroxycyclohex-2-en-1-yl benzoate
6-(acetyloxy)-2-[(benzoyloxy)methyl]-4,5-dihydroxycyclohex-2-en-1-yl benzoate
5-(2-hydroxy-1-methanesulfonylpropan-2-yl)-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
(1r,14r)-11,14-dihydroxy-17,18-dimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-3,5,9,11,15(20),16,18-heptaen-13-one
6-[(6,8-dihydroxy-3,7-dimethyl-1-oxo-3,4-dihydro-2-benzopyran-5-yl)methyl]-5-hydroxy-7-methoxy-2-methylchromen-4-one
6-{[(3r)-6,8-dihydroxy-3,7-dimethyl-1-oxo-3,4-dihydro-2-benzopyran-5-yl]methyl}-5-hydroxy-7-methoxy-2-methylchromen-4-one
2-(2h-1,3-benzodioxol-5-yl)-5-hydroxy-3,8-dimethoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
(2r,2's,4s,6s,7s,10s,12s)-2',12,17-trihydroxy-6-methyl-3,8-dioxaspiro[hexacyclo[11.8.0.0²,⁴.0²,¹⁰.0⁶,¹⁰.0¹⁴,¹⁹]henicosane-7,3'-oxolane]-1(13),14,16,18-tetraene-5',20-dione
11-hydroxytephrosin
{"Ingredient_id": "HBIN000455","Ingredient_name": "11-hydroxytephrosin","Alias": "NA","Ingredient_formula": "C23H22O8","Ingredient_Smile": "CC1(C=CC2=C(O1)C=C(C3=C2OC4COC5=CC(=C(C=C5C4(C3=O)O)OC)OC)O)C","Ingredient_weight": "426.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10740","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "124355889","DrugBank_id": "NA"}